Study finds hand-held ultrasound device improves diagnosis of heart disease

GE Healthcare's Vscan hand-held ultrasound device--Courtesy of GE Healthcare.

Medical students who were trained to diagnose valvular heart disease using hand-held echocardiography technology performed better than students trained to diagnose the disease using only traditional methods, such as listening for heart murmurs with a stethoscope. Among students trained using only traditional methods, 40% correctly diagnosed valvular heart disease on the final exam, while 58% of those trained in the use of the ultrasound device were able to do so. Both sets of students were shown a video of echocardiograms. The device used in the study was GE Healthcare's ($GE) Vscan. The results were released at the American Heart Association meeting in Chicago. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.